Micro Laboratories Inc. (fka MLAR)

[jcinvestny]

Micro Laboratories, Inc. and United States Basketball League Announce Joint Venture Agreements
Thursday September 22, 9:15 am ET


JOHNSTON, R.I., Sept. 22 /PRNewswire-FirstCall/ -- Micro Laboratories, Inc. (OTC Bulletin Board: MLAR - News) announces a joint venture agreement between the United States Basketball League (OTC Bulletin Board: USBL - News) and MLAR. The United States Basketball League, a twenty-one-year-old league, is to the basketball world what the AAA League is to baseball. The USBL will purchase Micro Spray Vitamin B-12 and other sprays for the use of all USBL players and personnel. Comments, feedback and testimony from the athletes will be available in the future. Robert Thistle, chairman of Micro Laboratories, states, "We are very excited about this agreement and we know that some of the NBA players are already using Micro Spray products and having very good results...This is just the tip of the iceberg; we are beginning to achieve brand recognition for Micro Spray. This product is not only patented, Patent #6,071,500, it also has a federally registered trademark, circle R. When our new website is up, we will be posting testimonials from people all over the country that are achieving great results from using Micro Spray products."
ADVERTISEMENT

WM
WM








About Micro Laboratories, Inc.

Micro Laboratories, Inc. has developed a full line of sublingual spray vitamins and nutrients that are intended to revolutionize the way people take their vitamins. Sublingual sprays are the most efficient, convenient and effective way of getting your vitamins and nutrients.

Safe Harbor Act Disclaimer: This press release contains statements which are forward-looking statements within the meaning of applicable federal securities laws and are based upon the Company's current expectations and assumptions which are subject to a number of risks and uncertainties which could cause actual results to materially differ from those anticipated.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.